[Ovid] Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results (S16.010)

 Close Closed
TTr Post time 2024-5-7 23:56:12 | Show all posts |Read mode
Reward10points

journal£ºNeurology

Authors£ºJiwon Oh; Sana Syed; Tong Li; Naji Salloum; Timothy J. Turner; Robert J. Fox

Published date£º2023-4-25

DOI£º10.1212/wnl.0000000000202287

PDF link£ºhttps://syndication.highwire.org ... NL.0000000000202287

Article link£ºhttp://dx.doi.org/10.1212/wnl.0000000000202287

Article Source£ºOvid Technologies (Wolters Kluwer Health)¡£


Remark£º
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    70

Latest Reply

Return to the list